GSK vs LLY: Which Stock is Better?
Side-by-side comparison of GlaxoSmithKline PLC ADR and Eli Lilly and Company in 2026
GSK
GlaxoSmithKline PLC ADR
—
LLY
Eli Lilly and Company
$1146.90
Key Metrics Comparison
| Metric | GSK | LLY | Winner |
|---|---|---|---|
| Market Cap | $103.31B | $991.62B | LLY |
| P/E Ratio | 13.49 | 39.47 | GSK |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GSK
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GSK or LLY a better investment?
Comparing GSK and LLY: GlaxoSmithKline PLC ADR has a market cap of $103.31B while Eli Lilly and Company has $991.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GSK and LLY?
GSK (GlaxoSmithKline PLC ADR) and LLY (Eli Lilly and Company) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GSK or LLY?
Based on P/E ratios, GSK trades at a lower multiple (13.5x vs 39.5x).
Which is growing faster: GSK or LLY?
Both GSK and LLY show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GSK or LLY?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GSK or LLY?
Eli Lilly and Company (LLY) is larger with a market cap of $991.62B compared to $103.31B for GSK.
Should I buy GSK or LLY in 2026?
Both GSK and LLY have investment merit. GSK trades at $N/A while LLY trades at $1146.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GSK and LLY stock?
Key differences: Market Cap ($103.31B vs $991.62B), P/E Ratio (13.5x vs 39.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GSK or LLY in 2026?
The choice between GSK and LLY depends on your investment goals. LLY shows higher revenue growth (0.0%). LLY has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GSK and LLY?
GSK (GlaxoSmithKline PLC ADR) has a market cap of $103.31B, while LLY (Eli Lilly and Company) has a market cap of $991.62B. LLY is the larger company by market value.